Rekah Pharmaceutical Industry Ltd. (REKA.TA)
Tel Aviv · ILA · Healthcare · Drug Manufacturers - Specialty & Generic
ILA 1,020.00 (-0.58%) as of
Key statistics
- Market cap
- 116.43M
- EPS (TTM)
- -1.40
- Dividend yield
- 0.00%
- 52-week range
- 1,006.00 – 1,348.00
- Beta
- 0.10
- Revenue (TTM)
- 304.04M
- Profit margin
- -5.20%
- Volume
- 1.00k
About Rekah Pharmaceutical Industry Ltd.
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, eye infections, glaucoma, dryness, allergies, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, antibiotics, fungal infections, anemia and nutritional deficits, ear pain, babies and children, etc. The company was founded in 1947 and is based in Holon, Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Holon, Israel
- Employees
- 390
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.